These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 47966)

  • 1. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Banes D
    Lancet; 1975 Mar; 1(7907):629. PubMed ID: 47966
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Feb; 1(7902):343. PubMed ID: 46493
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Digoxin tablets: a possible problem with biological availability.
    Am Heart J; 1973 Nov; 86(5):715. PubMed ID: 4800276
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin bioavailability: evaluation of a generic tablet and proposed FDA guidelines.
    Kramer WG; Kolibash AJ; Bathala MS; Visconti JA; Lewis RP; Reuning RH
    J Pharm Sci; 1977 Dec; 66(12):1720-2. PubMed ID: 925936
    [No Abstract]   [Full Text] [Related]  

  • 5. The bioavailability of other digoxin preparations compared with tablets.
    Johnson BF; Bye C; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():62-6. PubMed ID: 4459892
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control of digoxin tablets.
    Caws AC; Jenkins DJ; McCrerie JA
    Postgrad Med J; 1974 Nov; 50 Suppl 6():37-40. PubMed ID: 4459886
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Improving the bioavailability of digoxin.
    Binnion PF; Klopp RW
    Lancet; 1975 Jun; 1(7922):1422-3. PubMed ID: 49581
    [No Abstract]   [Full Text] [Related]  

  • 9. The dissolution rate of digoxin tablets on the U.K. market: the scale of the problem.
    Cowan DA; Beckett AH
    Postgrad Med J; 1974 Nov; 50 Suppl 6():52-5. PubMed ID: 4459889
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-equivalence of digoxin tablets in the U.K. and its clinical implications.
    Shaw TR
    Postgrad Med J; 1974 Nov; 50 Suppl 6():24-9. PubMed ID: 4459884
    [No Abstract]   [Full Text] [Related]  

  • 11. Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Mar; 1(7909):744. PubMed ID: 47503
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
    Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: What the practicing physician should know about digoxin bioavailability and how will FDA action affect him?
    Circulation; 1974 Mar; 49(3):399-400. PubMed ID: 4813171
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.
    Fletcher S; Summers RS
    S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 20. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.